AIM ImmunoTech Inc (AIM)

2.58 -0.09  -3.37% NYSE AM Jul 10, 13:11 Real time USD
View Full Chart
Price Chart
View All Events

Events

Date Type Description
08/17/2020 Earnings AIM ImmunoTech Inc Second Quarter Earnings Results for 2020
05/14/2020 Earnings AIM ImmunoTech Inc First Quarter Earnings Results for 2020
03/31/2020 Earnings AIM ImmunoTech Inc Fourth Quarter Earnings Results for 2019
03/30/2020 Misc AIM ImmunoTech Inc Annual Report for 2019
10/03/2019 10:00 EDT Misc AIM ImmunoTech Inc Annual General Meeting for 2018
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • URL: https://www.aimimmuno.com
  • Investor Relations URL: http://ir.hemispherx.net/
  • HQ State/Province: Florida
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Blend
  • Next Earnings Release: Aug. 17, 2020
  • Last Earnings Release: May. 14, 2020
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A
  • Description: AIM ImmunoTech Inc is a US-based specialty pharmaceutical company. It is engaged in the clinical development of drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune-based disorders. The products of the firm are Alferon N Injection and the experimental therapeutic Ampligen. Alferon N Injection is approved for a category of STD infection, and Ampligen represents a RNA being developed for viral diseases and disorders of the immune system. The sales revenue of the company is derived from the United States.

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.